Evaluation of a Communication Campaign To Improve Continuation Among First-Time Injectable Contraceptive Users in Nyando District, Kenya

被引:4
作者
Burke, Holly McClain [1 ]
Ambasa-Shisanya, Constance [1 ]
机构
[1] Exceed Consultancy Serv, Nairobi, Kenya
关键词
QUALITY-OF-CARE; MEDROXYPROGESTERONE ACETATE; DISCONTINUATION; DETERMINANTS; COUNTRIES; RATES; WOMEN;
D O I
10.1363/4005614
中图分类号
C921 [人口统计学];
学科分类号
摘要
CONTEXT: Communication campaigns might be a viable means of improving contraceptive continuation; however, few such interventions aimed at reducing contraceptive discontinuation have been evaluated. METHODS: Data were collected from independent samples of new injectable users in Nyando District, Kenya site of a communication campaign to increase contraceptive continuation and in a comparison district, nine months before and nine months after intervention implementation. Survival analysis was used to compare the intervention and comparison groups with respect to the distribution of time until first discontinuation of modern method use among women still in need of family planning. RESULTS: Exposure to family planning information was high in both the treatment and the comparison district before (97% and 85%, respectively) and after the intervention (99% and 78%). Postintervention, 5% of women in the comparison district discontinued by 98 days, 8% by 196 days and 23% by 294 days; the proportions in the treatment district were 4%, 6% and 16%, respectively. No significant difference between the districts was found in the nine-month postintervention contraceptive continuation rates. Having method-related side effects or health concerns was the reason most consistently associated with discontinuation. Other factors associated with discontinuation differed between the districts. CONCLUSIONS: Addressing method-related side effects and health concerns will be critical in improving continuation of the injectable.
引用
收藏
页码:56 / 67
页数:12
相关论文
共 39 条
[31]   MASS-MEDIA FAMILY-PLANNING PROMOTION IN 3 NIGERIAN CITIES [J].
PIOTROW, PT ;
RIMON, JG ;
WINNARD, K ;
KINCAID, DL ;
HUNTINGTON, D ;
CONVISSER, J .
STUDIES IN FAMILY PLANNING, 1990, 21 (05) :265-274
[32]   Early experience with the contraceptive use of depot medroxyprogesterone acetate in an inner-city clinic population [J].
Polaneczky, M ;
Guarnaccia, M ;
Alon, J ;
Wiley, J .
FAMILY PLANNING PERSPECTIVES, 1996, 28 (04) :174-178
[33]   The link between quality of care and contraceptive use [J].
RamaRao, S ;
Lacuesta, M ;
Costello, M ;
Pangolibay, B ;
Jones, H .
INTERNATIONAL FAMILY PLANNING PERSPECTIVES, 2003, 29 (02) :76-83
[34]   Contraception to prevent HIV-positive births: current contribution and potential cost savings in PEPFAR countries [J].
Reynolds, H. W. ;
Janowitz, B. ;
Wilcher, R. ;
Cates, W. .
SEXUALLY TRANSMITTED INFECTIONS, 2008, 84 :II49-II53
[35]   The value of contraception to prevent perinatal HIV transmission [J].
Reynolds, Heidi W. ;
Janowitz, Barbara ;
Homan, Rick ;
Johnson, Laura .
SEXUALLY TRANSMITTED DISEASES, 2006, 33 (06) :350-356
[36]   The impact of family planning service provision on contraceptive-use dynamics in Morocco [J].
Steele, F ;
Curtis, SL ;
Choe, M .
STUDIES IN FAMILY PLANNING, 1999, 30 (01) :28-42
[37]  
Westoff C. F., 1995, International Family Planning Perspectives, V21, P26, DOI 10.2307/2133602
[38]  
Westoff C.F., 1997, DEMOGRAPHIC HLTH SUR
[39]   ASSESSING THE ACCEPTABILITY OF NORPLANT IMPLANTS IN 4 COUNTRIES - FINDINGS FROM FOCUS GROUP RESEARCH [J].
ZIMMERMAN, M ;
HAFFEY, J ;
CRANE, E ;
SZUMOWSKI, D ;
ALVAREZ, F ;
BHIROMRUT, P ;
BRACHE, V ;
LUBIS, F ;
SALAH, M ;
SHAABAN, M ;
SHAWKY, B ;
SIDI, IPS .
STUDIES IN FAMILY PLANNING, 1990, 21 (02) :92-103